Lifetime (to age 80–85 y) cumulative incidence of dementia by baseline age and APOE-e4 dose.

APOE-ε4 count predicts age when prevalence of AD increases, then declines

Breitner, J. C. S.
Wyse, Bonita W.
Anthony, J. C.
Welsh-Bohmer, K. A.
Steffens, D. C.
Norton, Maria C.
Tschanz, JoAnn T.
Plassman, B. L.
Meyer, M. R.
Skoog, I.
Khachaturian, A.

July 1999

Objective: To examine the prevalence of Alzheimer’s disease (AD) and other dementias in relation to ...

Qian, J. (Jing)
Wolters, Frank
Beiser, Alexa
Haan, M. (Mary)
Ikram, Kamran
Karlawish, J. (Jason)
Langbaum, J.B. (Jessica B.)
Neuhaus, J.M. (John M.)
Reiman, Eric
Roberts, Scott
Seshadri, Sudha
Tariot, P.N. (Pierre N.)
Woods, B.M. (Beth McCarty)
Betensky, R.A. (Rebecca A.)
Blacker, Deborah

March 2017

textabstractBackground: With the onset of prevention trials for individuals at high risk for Alzheim...

Estimating the lifetime risk of dementia using nationwide individually linked cause-of-death and health register data

Klijs, Bart
Mitratza, Marianna
Harteloh, Peter Pm
Moll van Charante, Eric P.
Richard, Edo
Nielen, Markus Mj
Kunst, Anton E.

June 2021

BACKGROUND: Previous estimates of the lifetime risk of dementia are restricted to older age groups a...

Five-year cumulative incidence of dementia by baseline age and APOE-e4 dose.

Jing Qian (170232)
Frank J. Wolters (3208329)
Alexa Beiser (540215)
Mary Haan (3850348)
M. Arfan Ikram (135636)
Jason Karlawish (140210)
Jessica B. Langbaum (3850345)
John M. Neuhaus (3850354)
Eric M. Reiman (295549)
J. Scott Roberts (3850342)
Sudha Seshadri (79956)
Pierre N. Tariot (3850339)
Beth McCarty Woods (3850351)
Rebecca A. Betensky (442911)
Deborah Blacker (28889)

March 2017

Five-year cumulative incidence of dementia by baseline age and APOE-e4 dose.</p

Five-year cumulative incidence of mild cognitive impairment/dementia by baseline age and APOE-e4 dose.

Jing Qian (170232)
Frank J. Wolters (3208329)
Alexa Beiser (540215)
Mary Haan (3850348)
M. Arfan Ikram (135636)
Jason Karlawish (140210)
Jessica B. Langbaum (3850345)
John M. Neuhaus (3850354)
Eric M. Reiman (295549)
J. Scott Roberts (3850342)
Sudha Seshadri (79956)
Pierre N. Tariot (3850339)
Beth McCarty Woods (3850351)
Rebecca A. Betensky (442911)
Deborah Blacker (28889)

March 2017

Five-year cumulative incidence of mild cognitive impairment/dementia by baseline age and APOE<...

Cognitive Performance over Time and APOE4 in Non-Demented Oldest-Old

Balasubramanian, Archana
Kawas, Claudia
Peltz, Carrie
Corrada-Bravo, Maria

April 2012

Abstract Objective: To determine if cognitive performance over time is related to the APOE4 allele i...

The estimated transition probability matrix of clinical dementia rating (CDRGLOB) in Alzheimer's disease patients at the age of 55 or 85 and carrying no, one, or two APOE- 4 alleles.

Wei Liu (20030)
Bo Zhang (6559)
Zhiwei Zhang (12077)
Xiao-Hua Zhou (345533)

September 2013

The estimated transition probability matrix of clinical dementia rating (CDRGLOB) in Alzheimer's ...

Age-dependent effects of APOE ε4 in preclinical Alzheimer's disease.

Bonham, Luke W
Geier, Ethan G
Fan, Chun C
Leong, Josiah K
Besser, Lilah
Kukull, Walter A
Kornak, John
Andreassen, Ole A
Schellenberg, Gerard D
Rosen, Howard J
Dillon, William P
Hess, Christopher P
Miller, Bruce L
Dale, Anders M
Desikan, Rahul S
Yokoyama, Jennifer S

September 2016

The ε4 allele of apolipoprotein E (APOE) is the strongest known common genetic risk factor for Alzhe...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

January 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

Qian, Jing
Wolters, Frank J.
Beiser, Alexa
Haan, Mary
Ikram, M. Arfan
Karlawish, Jason
Langbaum, Jessica B.
Neuhaus, John M.
Reiman, Eric M.
Roberts, J. Scott
Seshadri, Sudha
Tariot, Pierre N.
Woods, Beth McCarty
Betensky, Rebecca A.
Blacker, Deborah

March 2017

Background With the onset of prevention trials for individuals at high risk for Alzheimer disease, t...

Association of Apolipoprotein E-e4 and Dementia Declines with Age

Valerio Aguilar, Daniel
Raventós Vorst, Henriette
Schmeidler, James
Beeri, Michal S.
Mora Villalobos, Lara
Bolaños Palmieri, Patricia
Carrión Baralt, José R.
Fornaguera Trías, Jaime
Silverman, Jeremy M.

October 2014

To study the association of dementia with apolipoprotein E-e4 (APOE-e4) and its interaction with age...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

March 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

March 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

APOE-ε4 count predicts age when prevalence of AD increases, then declines

Breitner, J. C. S.
Wyse, Bonita W.
Anthony, J. C.
Welsh-Bohmer, K. A.
Steffens, D. C.
Norton, Maria C.
Tschanz, JoAnn T.
Plassman, B. L.
Meyer, M. R.
Skoog, I.
Khachaturian, A.

July 1999

Objective: To examine the prevalence of Alzheimer’s disease (AD) and other dementias in relation to ...

Adjusted Hazard Ratios (HR) of Dementia Because of mTBI in Patients Older than 65 Years.

Yi-Kung Lee (409204)
Sheng-Wen Hou (409205)
Ching-Chih Lee (113210)
Chen-Yang Hsu (409206)
Yung-Sung Huang (113199)
Yung-Cheng Su (325224)

May 2013

Adjusted Hazard Ratios (HR) of Dementia Because of mTBI in Patients Older than 65 Years.</p

APOE-ε4 count predicts age when prevalence of AD increases, then declines

Breitner, J. C. S.
Wyse, Bonita W.
Anthony, J. C.
Welsh-Bohmer, K. A.
Steffens, D. C.
Norton, Maria C.
Tschanz, JoAnn T.
Plassman, B. L.
Meyer, M. R.
Skoog, I.
Khachaturian, A.

July 1999

Objective: To examine the prevalence of Alzheimer’s disease (AD) and other dementias in relation to ...

Qian, J. (Jing)
Wolters, Frank
Beiser, Alexa
Haan, M. (Mary)
Ikram, Kamran
Karlawish, J. (Jason)
Langbaum, J.B. (Jessica B.)
Neuhaus, J.M. (John M.)
Reiman, Eric
Roberts, Scott
Seshadri, Sudha
Tariot, P.N. (Pierre N.)
Woods, B.M. (Beth McCarty)
Betensky, R.A. (Rebecca A.)
Blacker, Deborah

March 2017

textabstractBackground: With the onset of prevention trials for individuals at high risk for Alzheim...

Estimating the lifetime risk of dementia using nationwide individually linked cause-of-death and health register data

Klijs, Bart
Mitratza, Marianna
Harteloh, Peter Pm
Moll van Charante, Eric P.
Richard, Edo
Nielen, Markus Mj
Kunst, Anton E.

June 2021

BACKGROUND: Previous estimates of the lifetime risk of dementia are restricted to older age groups a...

Five-year cumulative incidence of dementia by baseline age and APOE-e4 dose.

Jing Qian (170232)
Frank J. Wolters (3208329)
Alexa Beiser (540215)
Mary Haan (3850348)
M. Arfan Ikram (135636)
Jason Karlawish (140210)
Jessica B. Langbaum (3850345)
John M. Neuhaus (3850354)
Eric M. Reiman (295549)
J. Scott Roberts (3850342)
Sudha Seshadri (79956)
Pierre N. Tariot (3850339)
Beth McCarty Woods (3850351)
Rebecca A. Betensky (442911)
Deborah Blacker (28889)

March 2017

Five-year cumulative incidence of dementia by baseline age and APOE-e4 dose.</p

Five-year cumulative incidence of mild cognitive impairment/dementia by baseline age and APOE-e4 dose.

Jing Qian (170232)
Frank J. Wolters (3208329)
Alexa Beiser (540215)
Mary Haan (3850348)
M. Arfan Ikram (135636)
Jason Karlawish (140210)
Jessica B. Langbaum (3850345)
John M. Neuhaus (3850354)
Eric M. Reiman (295549)
J. Scott Roberts (3850342)
Sudha Seshadri (79956)
Pierre N. Tariot (3850339)
Beth McCarty Woods (3850351)
Rebecca A. Betensky (442911)
Deborah Blacker (28889)

March 2017

Five-year cumulative incidence of mild cognitive impairment/dementia by baseline age and APOE<...

Cognitive Performance over Time and APOE4 in Non-Demented Oldest-Old

Balasubramanian, Archana
Kawas, Claudia
Peltz, Carrie
Corrada-Bravo, Maria

April 2012

Abstract Objective: To determine if cognitive performance over time is related to the APOE4 allele i...

The estimated transition probability matrix of clinical dementia rating (CDRGLOB) in Alzheimer's disease patients at the age of 55 or 85 and carrying no, one, or two APOE- 4 alleles.

Wei Liu (20030)
Bo Zhang (6559)
Zhiwei Zhang (12077)
Xiao-Hua Zhou (345533)

September 2013

The estimated transition probability matrix of clinical dementia rating (CDRGLOB) in Alzheimer's ...

Age-dependent effects of APOE ε4 in preclinical Alzheimer's disease.

Bonham, Luke W
Geier, Ethan G
Fan, Chun C
Leong, Josiah K
Besser, Lilah
Kukull, Walter A
Kornak, John
Andreassen, Ole A
Schellenberg, Gerard D
Rosen, Howard J
Dillon, William P
Hess, Christopher P
Miller, Bruce L
Dale, Anders M
Desikan, Rahul S
Yokoyama, Jennifer S

September 2016

The ε4 allele of apolipoprotein E (APOE) is the strongest known common genetic risk factor for Alzhe...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

January 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

Qian, Jing
Wolters, Frank J.
Beiser, Alexa
Haan, Mary
Ikram, M. Arfan
Karlawish, Jason
Langbaum, Jessica B.
Neuhaus, John M.
Reiman, Eric M.
Roberts, J. Scott
Seshadri, Sudha
Tariot, Pierre N.
Woods, Beth McCarty
Betensky, Rebecca A.
Blacker, Deborah

March 2017

Background With the onset of prevention trials for individuals at high risk for Alzheimer disease, t...

Association of Apolipoprotein E-e4 and Dementia Declines with Age

Valerio Aguilar, Daniel
Raventós Vorst, Henriette
Schmeidler, James
Beeri, Michal S.
Mora Villalobos, Lara
Bolaños Palmieri, Patricia
Carrión Baralt, José R.
Fornaguera Trías, Jaime
Silverman, Jeremy M.

October 2014

To study the association of dementia with apolipoprotein E-e4 (APOE-e4) and its interaction with age...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

March 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

Qian, Jing
Wolters, Frank J
Beiser, Alexa
Haan, Mary
Ikram, M Arfan
Karlawish, Jason
Langbaum, Jessica B
Neuhaus, John M
Reiman, Eric M
Roberts, J Scott
Seshadri, Sudha
Tariot, Pierre N
Woods, Beth McCarty
Betensky, Rebecca A
Blacker, Deborah

March 2017

BackgroundWith the onset of prevention trials for individuals at high risk for Alzheimer disease, th...

APOE-ε4 count predicts age when prevalence of AD increases, then declines

Breitner, J. C. S.
Wyse, Bonita W.
Anthony, J. C.
Welsh-Bohmer, K. A.
Steffens, D. C.
Norton, Maria C.
Tschanz, JoAnn T.
Plassman, B. L.
Meyer, M. R.
Skoog, I.
Khachaturian, A.

July 1999

Objective: To examine the prevalence of Alzheimer’s disease (AD) and other dementias in relation to ...

Adjusted Hazard Ratios (HR) of Dementia Because of mTBI in Patients Older than 65 Years.

Yi-Kung Lee (409204)
Sheng-Wen Hou (409205)
Ching-Chih Lee (113210)
Chen-Yang Hsu (409206)
Yung-Sung Huang (113199)
Yung-Cheng Su (325224)

May 2013

Adjusted Hazard Ratios (HR) of Dementia Because of mTBI in Patients Older than 65 Years.</p

APOE-ε4 count predicts age when prevalence of AD increases, then declines

Breitner, J. C. S.
Wyse, Bonita W.
Anthony, J. C.
Welsh-Bohmer, K. A.
Steffens, D. C.
Norton, Maria C.
Tschanz, JoAnn T.
Plassman, B. L.
Meyer, M. R.
Skoog, I.
Khachaturian, A.

July 1999

Objective: To examine the prevalence of Alzheimer’s disease (AD) and other dementias in relation to ...

Qian, J. (Jing)
Wolters, Frank
Beiser, Alexa
Haan, M. (Mary)
Ikram, Kamran
Karlawish, J. (Jason)
Langbaum, J.B. (Jessica B.)
Neuhaus, J.M. (John M.)
Reiman, Eric
Roberts, Scott
Seshadri, Sudha
Tariot, P.N. (Pierre N.)
Woods, B.M. (Beth McCarty)
Betensky, R.A. (Rebecca A.)
Blacker, Deborah

March 2017

textabstractBackground: With the onset of prevention trials for individuals at high risk for Alzheim...

Estimating the lifetime risk of dementia using nationwide individually linked cause-of-death and health register data

Klijs, Bart
Mitratza, Marianna
Harteloh, Peter Pm
Moll van Charante, Eric P.
Richard, Edo
Nielen, Markus Mj
Kunst, Anton E.

June 2021

BACKGROUND: Previous estimates of the lifetime risk of dementia are restricted to older age groups a...

Lifetime (to age 80–85 y) cumulative incidence of dementia by baseline age and <i>APOE</i>-e4 dose.

Abstract

Extracted data

Lifetime (to age 80–85 y) cumulative incidence of dementia by baseline age and <i>APOE</i>-e4 dose.

Abstract

Extracted data

Related items

Related items